Trade NVCT stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Nuvectis Pharma, Inc. (NVCT) is trading at US$19.69, down 6.77% today as of Oct 12, 16:00 EDT. The company has a market capitalisation of US$767.62M. Over the past 52 weeks, NVCT has traded between US$5.55 and US$29.28. On Syfe you can trade NVCT with $0 commission and add it to your watchlist.
| Previous close | US$21.12 |
|---|---|
| Market cap | US$767.62M |
| 52-week range | US$5.55 – US$29.28 |
| Volume | 145.83K |
| Exchange | US |
Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. Its product pipeline includes NXP800 and NXP900. The company was founded by Ronald E. Bentsur, Enrique Poradosu, and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.
Year: 2022
--Cantor Fitzgerald Initiates Coverage on Nuvectis Pharma With Overweight Rating
Aug 24, 11:21 AM · MT Newswires
Nuvectis Pharma Says Paroxysmal Nocturnal Hemoglobinuria Drug Approved by Chinese Regulator
Jul 23, 1:07 PM · MT Newswires
Nuvectis Pharma Insider Bought Shares Worth $916,000, According to a Recent SEC Filing
Jul 1, 5:47 PM · MT Newswires
Top Premarket Decliners
Jun 30, 11:35 AM · MT Newswires
Nuvectis Pharma, Inc. (NVCT) stock is trading at US$19.69, -6.77% from the previous close of US$21.12.
The market cap for Nuvectis Pharma, Inc. (NVCT) stock is approximately US$767.62M.
The 52-week high for Nuvectis Pharma, Inc. (NVCT) stock is US$29.28.
The 52-week low for Nuvectis Pharma, Inc. (NVCT) stock is US$5.55.
Nuvectis Pharma, Inc. (NVCT) does not currently pay a dividend.
Stay on top of NVCT
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
